Adverse events58

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 58

Type	Event	Organ system	Group	Affected	At risk
other	Bronchitis	Infections and infestations	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	0	96
other	Bronchitis	Infections and infestations	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	2	96
other	Cough	Respiratory, thoracic and mediastinal disorders	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	2	96
other	Cough	Respiratory, thoracic and mediastinal disorders	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	0	96
other	Diarrhoea	Gastrointestinal disorders	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	2	96
other	Diarrhoea	Gastrointestinal disorders	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	1	96
other	Epilepsy	Nervous system disorders	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	3	96
other	Epilepsy	Nervous system disorders	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	1	96
other	Fall	Injury, poisoning and procedural complications	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	0	96
other	Fall	Injury, poisoning and procedural complications	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	2	96
other	Headache	Nervous system disorders	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	2	96
other	Headache	Nervous system disorders	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	0	96
other	Haematoma	Vascular disorders	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	0	96
other	Haematoma	Vascular disorders	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	2	96
other	Injection site haematoma	General disorders	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	0	96
other	Injection site haematoma	General disorders	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	4	96
other	Injection site pain	General disorders	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	2	96
other	Injection site pain	General disorders	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	0	96
other	Limb injury	Injury, poisoning and procedural complications	incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL	0	96
other	Limb injury	Injury, poisoning and procedural complications	incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL	2	96

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00465738/events

API reference For AI assistants

Adverse events58

Sources 3

Read this list from software.